NAL Pharmaceutical Group Limited

About NAL Pharmaceutical Group Limited

NAL is developing proprietary, non-infringing DDS drug products including rDNA-engineered tumor-targeting nanoparticle and microsphere extended-release injectables, transdermal patches, sublingual oral films, and solids, based on captive DDS.

  • HK
  • 2017
    On CPHI since
Contact info

Products from NAL Pharmaceutical Group Limited (3)

  • Bio-FX Sublingual Orally-Dissolving Film (ODF) DDS

    Product Bio-FX Sublingual Orally-Dissolving Film (ODF) DDS

    NAL Pharmaceutical Group Limited offers captive DDS technology which includes Bio-FX sublingual orally-dissolving film (ODF) DDS. It acts as an innovative dosage form principally for sublingual or oral cavity absorption, orally dissolving film (“ODF”) is formulated with a proprietary Bio-FX absorption enhance...
  • Bio-D3 Transdermal Patch DDS

    Product Bio-D3 Transdermal Patch DDS

    NAL Pharmaceutical Group Limited offers captive DDS technology which includes Bio-D3 transdermal patch DDS.it is employed with proprietary Bio-D3 skin penetration enhancers to develop a wide range of patch delivery systems varying from localized action to transdermal absorption for up to 7 days. The new gener...
  • Bio-CR Oral Controlled-Release DDS

    Product Bio-CR Oral Controlled-Release DDS

    NAL Pharmaceutical Group Limited offers captive DDS technology which includes Bio-CR oral controlled-release DDS. It is incorporated with captive API of proprietary manufacturing process and/or proprietary crystalline forms, coupled with non-infringing formulation/manufacturing process know-how, thereby allow...